Background illustration for clinical trials search

Paid Clinical Trials California

Discover 5,739 paid clinical trials in California. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Ductal Adenocarcinoma (mPDAC)
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT06790602

Phase2, Recruiting

Retifanlimab and Ruxolitinib In Solid Malignancies

for
Non Small Cell Lung Carcinoma, Renal Cell Carcinoma
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 0+

Code: NCT07219576

Phase1, Phase2, Recruiting

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

for
AChR-Ab Seropositive Generalized Myasthenia Gravis,
Location: Boston MA, Durham NC, Miami FL, Amherst NY, Tampa FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07284420

Phase2, Recruiting

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

for
Multiple Sclerosis (MS) Primary Progressive
Location: Livingston NJ, Raleigh NC, Maitland FL, Tampa FL,
Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07067463

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

for
Focal Seizures
Location: New Haven CT, Hawthorne NY, New Brunswick NJ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT07233239

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Scarborough ME, Burlington MA, New Haven CT, Norfolk VA,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children

for
Income, Infant, Newborn, Mothers, Poverty, United States,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT07261254

Recruiting

Study of Student Flourishing

for
Healthy
Location: Madison WI, Manhattan KS, Victoria, Orange CA,
Sponsor: Flourish Science, Inc.

Sex: All

Age: 18+

Code: NCT07259746

Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

for
Head and Neck Squamous Cell Carcinoma,
Location: Richmond VA, Pittsburgh PA, Atlanta GA, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06980038

Phase2, Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Toronto, Franklin TN, Chicago IL, Iowa City IA,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07109219

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Halifax, Foxborough MA, Wellesley MA, Worchester MA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase3, Recruiting

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Charlottesville VA, Pittsburgh PA, Wesley Chapel FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07012031

Phase1, Phase2, Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

for
Primary Immunoglobulin A Nephropathy (IgAN)
Location: Philadelphia PA, Gainesville FL, Aurora CO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 18

Code: NCT06994845

Phase3, Recruiting

EVR and EPO for Liver Transplant Tolerance

for
Liver Transplant
Location: Philadelphia PA, Chicago IL, San Francisco CA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT06832189

Phase1, Recruiting

An International Observational Study of Adults With Acute Infection

for
Infectious Disease
Location: New York NY, Durham NC, Winston-Salem NC, Morgantown WV,
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT07069400

Recruiting

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

for
Connective Tissue Diseases
Location: New York NY, Philadelphia PA, Los Angeles CA
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06716606

Phase3, Recruiting

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

for
Peripheral Arterial Disease
Location: Levis, Laval, Virginia Beach VA, Bowie MD, Camp Hill PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07223593

Phase3, Recruiting

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

for
Type 1 Diabetes
Location: San Francisco CA
Sponsor: Sanofi

Sex: All

Age: 8+

Code: NCT07260110

Recruiting

Addressing Social Needs to Improve Health in Adults With Multiple Chronic Conditions

for
Multiple Chronic Conditions, Social Needs, Care Gaps,
Location: Pleasanton CA
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT06941519

Recruiting

A Study of NTX-1472 in Social Anxiety Disorder

for
Social Anxiety Disorder (SAD)
Location: Boston MA, Brooklyn NY, Jacksonville FL, Tampa FL,
Sponsor: Newleos Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT07323784

Phase2, Recruiting

Popular cities in California

With its extensive healthcare system and world-class medical research institutions, California is a major hub for clinical trials. Leading research centers such as UCLA Health, Stanford Medicine, the University of California, the City of Hope, San Francisco (UCSF), and the Scripps Research Institute are spearheading medical research and innovation. These institutions are at the cutting edge of clinical studies, driving advancements in groundbreaking treatments and significantly contributing to healthcare innovations across the state.

Why choose California for clinical trials?

The state of California offers a variety of benefits for participants in clinical trials. Firstly, because the state is home to leading research institutions, it provides participants with access to cutting-edge treatments and advanced medical technologies before they become widely available. These institutions are equipped with state-of-the-art facilities and staffed by top experts, ensuring high-quality care and rigorous monitoring throughout the study.

California's diverse and innovative research landscape offers a wide range of study options, enhancing the likelihood of finding a trial that matches specific health needs. Moreover, the state's adherence to stringent regulatory and ethical standards ensures that trials are conducted with the utmost integrity and participant protection.

Common conditions studied in California

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in California